You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 1345 mTFF2-MSA (mTNX-1700) suppresses tumor growth and increases survival in anti-PD-1 treated CT26.wt subcutaneous and CT26-Luciferase orthotopic syngeneic colorectal cancer models by targeting MDSCs

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Novel Single-Agent Immunotherapies
1345 mTFF2-MSA (mTNX-1700) suppresses tumor growth and increases survival in anti-PD-1 treated CT26.wt subcutaneous and CT26-Luciferase orthotopic syngeneic colorectal cancer models by targeting MDSCs

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 202311806
Dec 20237004
Jan 20243302
Feb 20244203
Mar 20243401
Apr 20241801
May 20242401
Jun 20241401
Jul 20241401
Aug 20241202
Sep 20241201
Oct 20241608
Nov 20244707
Dec 20242007
Jan 20251204
Feb 2025003
Mar 2025005
Apr 2025101
May 2025006
Jun 2025005
Total487069